Among them, 23 target proteins such as PTGS2, TNF and FOS were enriched in the IL-17 signalling pathway, indicating that the IL-17 signalling pathway plays an important role in the treatment of pneumonia by RYNM. This evidence concerns the gene IL17A and susceptibility to pneumonia measurement.